Search Results - "Tatyana V. Taksir"
-
1
Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis
Published in The Journal of neuroscience (18-11-2020)“…Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disease characterized by motor neuron (MN) death. Lipid dysregulation manifests during disease;…”
Get full text
Journal Article -
2
Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis
Published in Proceedings of the National Academy of Sciences - PNAS (25-06-2013)“…Metabolic dysfunction is an important modulator of disease course in amyotrophic lateral sclerosis (ALS). We report here that a familial mouse model…”
Get full text
Journal Article -
3
AAV4-mediated Expression of IGF-1 and VEGF Within Cellular Components of the Ventricular System Improves Survival Outcome in Familial ALS Mice
Published in Molecular therapy (01-12-2010)“…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron cell death in the cortex, brainstem, and spinal cord…”
Get full text
Journal Article -
4
Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer's disease
Published in Alzheimer's research & therapy (01-02-2022)“…Gangliosides are highly enriched in the brain and are critical for its normal development and function. However, in some rare neurometabolic diseases, a…”
Get full text
Journal Article -
5
Delivery of AAV-IGF-1 to the CNS Extends Survival in ALS Mice Through Modification of Aberrant Glial Cell Activity
Published in Molecular therapy (01-06-2008)“…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease of the motor system. Recent work in rodent models of ALS has shown that insulin-like…”
Get full text
Journal Article -
6
Combination Brain and Systemic Injections of AAV Provide Maximal Functional and Survival Benefits in the Niemann-Pick Mouse
Published in Proceedings of the National Academy of Sciences - PNAS (29-05-2007)“…Niemann-Pick disease (NPD) is caused by the loss of acid sphingomyelinase (ASM) activity, which results in widespread accumulation of undegraded lipids in…”
Get full text
Journal Article -
7
Gene Transfer of Human Acid Sphingomyelinase Corrects Neuropathology and Motor Deficits in a Mouse Model of Niemann-Pick Type A Disease
Published in Proceedings of the National Academy of Sciences - PNAS (06-12-2005)“…Niemann-Pick type A disease is a lysosomal storage disorder caused by a deficiency in acid sphingomyelinase (ASM) activity. Previously we showed that storage…”
Get full text
Journal Article -
8
Optimization of a Histopathological Biomarker for Sphingomyelin Accumulation in Acid Sphingomyelinase Deficiency
Published in The journal of histochemistry and cytochemistry (01-08-2012)“…Niemann-Pick disease (types A and B), or acid sphingomyelinase deficiency, is an inherited deficiency of acid sphingomyelinase, resulting in intralysosomal…”
Get full text
Journal Article -
9
Comparative analysis of acid sphingomyelinase distribution in the CNS of rats and mice following intracerebroventricular delivery
Published in PloS one (25-01-2011)“…Niemann-Pick A (NPA) disease is a lysosomal storage disorder (LSD) caused by a deficiency in acid sphingomyelinase (ASM) activity. Previously, we reported that…”
Get full text
Journal Article -
10
AAV Vector-Mediated Correction of Brain Pathology in a Mouse Model of Niemann–Pick A Disease
Published in Molecular therapy (01-05-2005)“…Niemann–Pick A disease (NPA) is a fatal lysosomal storage disorder caused by a deficiency in acid sphingomyelinase (ASM) activity. The lack of functional ASM…”
Get full text
Journal Article -
11
Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann–Pick A disease
Published in Experimental neurology (01-02-2009)“…Niemann–Pick A (NPA) disease is a lysosomal storage disorder (LSD) caused by a deficiency in acid sphingomyelinase (ASM) activity. Previously, we showed that…”
Get full text
Journal Article -
12
Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse
Published in Experimental neurology (01-02-2011)“…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of upper and lower motor neurons. However,…”
Get full text
Journal Article -
13
Relationship between neuropathology and disease progression in the SOD1G93A ALS mouse
Published in Experimental neurology (01-02-2011)Get full text
Journal Article -
14
Ability of adeno-associated virus serotype 8-mediated hepatic expression of acid alpha-glucosidase to correct the biochemical and motor function deficits of presymptomatic and symptomatic Pompe mice
Published in Human gene therapy (01-06-2008)“…The availability of a murine model of Pompe disease has enabled an evaluation of the relative merits of various therapeutic paradigms, including gene therapy…”
Get more information
Journal Article -
15
Optimized Preservation of CNS Morphology for the Identification of Glycogen in the Pompe Mouse Model
Published in The journal of histochemistry and cytochemistry (01-10-2007)“…Pompe disease (glycogenosis type II) is a rare lysosomal disorder caused by a mutational deficiency of acid α-glucosidase (GAA). This deficiency leads to…”
Get full text
Journal Article -
16
Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann–Pick A mouse
Published in Experimental neurology (01-10-2007)“…Niemann–Pick A disease (NPD-A) is caused by a deficiency of acid sphingomyelinase (ASM) leading to the intracellular accumulation of sphingomyelin and…”
Get full text
Journal Article -
17
2. Identification of Different Modes of Viral Transport in the Non-Human Primate Brain after Convection-Enhanced Delivery of AAV Serotype Vectors
Published in Molecular therapy (01-05-2006)“…Recombinant adeno-associated virus serotypes-1 and -2 encoding human acid sphingomyelinase were administered into multiple structures of the cynomolgus monkey…”
Get full text
Journal Article -
18
1062. Intracerebellar Injection of AAV-IGF-1 Improves Motor Function and Extends Survival in a Mouse Model of Amyotrophic Lateral Sclerosis
Published in Molecular therapy (01-05-2006)“…Amytrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by a selective loss of motor neurons in the motor cortex, brain…”
Get full text
Journal Article -
19
Mouse neural progenitor cells differentiate into oligodendrocytes in the brain of a knockout mouse model of Canavan disease
Published in Brain research. Developmental brain research (15-10-2004)“…Canavan disease (CD) is an autosomal recessive disorder that leads to spongy degeneration in the white matter of the brain. Aspartoacylase (ASPA) synthesizing…”
Get full text
Journal Article -
20
Relationship between neuropathology and disease progression in the SOD1 super(G93A) ALS mouse
Published in Experimental neurology (01-02-2011)“…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive loss of upper and lower motor neurons. However,…”
Get full text
Journal Article